Heverlee, Belgium

Piet Herdewyn

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Katholieke Universiteit Leuven Ku Leuven Research & Development, Leland Stanford Junior University, Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Piet Herdewyn. Retrieved from https://idiyas.com/inventor/piet-herdewyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Piet Herdewyn

Introduction

Piet Herdewyn is a notable inventor based in Heverlee, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral medications. His work focuses on novel compounds that have the potential to treat viral diseases effectively.

Latest Patents

Herdewyn holds a patent for "GAK modulators as antivirals." This invention relates to the use of a class of novel isothiazolo[4,3-b]pyridine derivatives. These derivatives are included in pharmaceutical compositions that contain one or more of these compounds along with pharmaceutically acceptable excipients. The primary application of this invention is as a medicament for treating various disorders and pathologic conditions, specifically viral diseases.

Career Highlights

Piet Herdewyn is affiliated with Leland Stanford Junior University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on public health, particularly in combating viral infections.

Collaborations

Herdewyn collaborates with esteemed colleagues such as Steven De Jonghe and Elena Bekerman. Their combined expertise enhances the research and development of effective antiviral therapies.

Conclusion

Piet Herdewyn's contributions to the field of antiviral medications exemplify the importance of innovation in healthcare. His patented work on isothiazolo[4,3-b]pyridine derivatives represents a promising advancement in the treatment of viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…